InvestorsHub Logo
Followers 0
Posts 718
Boards Moderated 0
Alias Born 12/08/2009

Re: dcspka post# 20782

Wednesday, 04/16/2014 8:36:05 PM

Wednesday, April 16, 2014 8:36:05 PM

Post# of 30046
dcspka, you said:

"The Uni agreement has already been voided due to non-payment of the $100,000 up front portion of a $500,000 licensing fee. "

Vester Guy says Radient is not filing with the SEC simply because they do not have to. The lack of SEC filings has us all guessing. It's a fun game, wouldn't you agree? I am confident that everyone realizes we are all stating conjecture.

So I think what you meant to say is this:

"I believe the Uni agreement has already been voided due to non-payment of the $100,000 up front portion of a $500,000 licensing fee. "

As for evidence that UNI is manufacturing DR-70 and not merely selling old stock per their 2011 licensing agreement with Radient: I think the shelf life of DR-70 is such that they could not be currently selling old test kits they bought in 2011. I think this is why SRL sold their remaining kits at half price and then stopped selling DR-70 altogether.

Radient has not been manufacturing DR-70 test kits for quite some time, to my knowledge. True, they might be secretly making test kits in a non-FDA-approved facility somewhere. I doubt that is the case, especially if they are being bought out/acquired by a takeover group with Deep Pockets. It seems far-fetched to say that Radient is secretly manufacturing test kits and selling them to UNI who is then selling them on other Asian websites, all under the 2011 licensing agreement.

But again -- all conjecture. In the case of this stock, I subscribe to the theory called "Ockham's Razor," which means the simplest explanation is probably true. That means there is no subterfuge with 4.9% sub-takeover-groups, no secret licensing agreements, no hiding anything from the SEC.

In other words: if you see nothing happening, then most likely, nothing is happening.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.